The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”
Keywords: AML, acute myeloid leukemia; AZA, 5-azacitidine; HCT-CI, hematopoietic cell transplantation comorbidity index; IPSS, International Prognostic Scoring System; IPSS-R, Revised International Prognostic Scoring System; MDS-CI, Myelodysplastic syndrome-specifi